@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix dc: . @prefix xsd: . @prefix owl: . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-RMSM6LXT-R skos:prefLabel "Adjuvants, Anesthesia"@en, "Adjuvants des anesthésiques"@fr ; a mesh:Descriptor, skos:Concept . jvr:-KW26S3M1-N skos:prefLabel "Anxiolytiques"@fr, "Anti-Anxiety Agents"@en ; a mesh:Descriptor, skos:Concept . jvr:-JZ05KW2D-1 skos:prefLabel "Benzodiazepines"@en, "Benzodiazépines"@fr ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-QQZD4RRS-Q . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-L4D1QCGV-8 skos:prefLabel "Hypnotics and Sedatives"@en, "Hypnotiques et sédatifs"@fr ; a mesh:Descriptor, skos:Concept . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-QQZD4RRS-Q mesh:allowableQualifier jvr:-L6C0XPHT-4, jvr:-TJHVZCRZ-0, jvr:-BT300B3G-Q, jvr:-M63HSDM7-1, jvr:-SBNWSM1T-R, jvr:-NKM836P1-M, jvr:-R3QWLHRG-V, jvr:-D0F21513-5, jvr:-T9HQD7ST-J, jvr:-XV06LPML-W, jvr:-Q3979798-W, jvr:-H7K65Q8S-Z, jvr:-W6SQV79N-S, jvr:-NB0XHT3S-N, jvr:-R0ZCQ8X6-J, jvr:-CB30NGKB-3, jvr:-NHL3D2X0-S, jvr:-THHNVC7V-3, jvr:-G4R176S9-J, jvr:-FWD2BGQ0-9, jvr:-NFTHND7Q-8, jvr:-S0CS1X5R-5, jvr:-G30ZJ446-J, jvr:-HQRFT0C6-B, jvr:-WK5F724J-1 ; skos:hiddenLabel "Bromhydrate de chlordiazépoxyde"@fr, "Chlordiazepoxide Hydrochloride"@en, "Librium"@en, "Elenium"@en, "Chlordiazepoxide Hydrobromide"@en, "Perchlorate de chlordiazépoxyde"@fr, "Chlorhydrate de chlordiazépoxyde"@fr, "Chlordiazepoxide Monohydrochloride"@en, "Chlordiazepoxide Perchlorate"@en, "Chlozepid"@en ; dc:modified "2017-01-17"^^xsd:date ; skos:altLabel "7-Chloro-2-methylamino-5-phenyl-3H-1,4-benzodiazepine-4-oxide"@en, "58-25-3 (Chlordiazepoxide)"@fr, "58-25-3 (Chlordiazepoxide)"@en, "Methaminodiazepoxide"@en, "MFM6K1XWDK"@en, "MFM6K1XWDK"@fr, "7-Chloro-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-amine 4-oxide"@en, "3H-1,4-Benzodiazepin-2-amine, 7-chloro-N-methyl-5-phenyl-, 4-oxide"@fr, "3H-1,4-Benzodiazepin-2-amine, 7-chloro-N-methyl-5-phenyl-, 4-oxide"@en, "14844-23-6 (HCl)"@fr, "14844-23-6 (HCl)"@en, "56617-98-2 (HBr)"@fr, "56617-98-2 (HBr)"@en, "121531-47-3 (mono-HClO4)"@fr, "121531-47-3 (mono-HClO4)"@en, "438-41-5 (mono-HCl)"@fr, "438-41-5 (mono-HCl)"@en, "6RZ6XEZ3CR"@fr, "6RZ6XEZ3CR"@en ; skos:broader jvr:-JZ05KW2D-1 ; mesh:pharmacologicalAction jvr:-KW26S3M1-N, jvr:-RMSM6LXT-R, jvr:-DW8H3MNZ-P, jvr:-L4D1QCGV-8 ; skos:prefLabel "Chlordiazepoxide"@en, "Chlordiazépoxyde"@fr ; a mesh:Descriptor, skos:Concept ; skos:definition "An anxiolytic benzodiazepine derivative with anticonvulsant, sedative, and amnesic properties. It has also been used in the symptomatic treatment of alcohol withdrawal."@en ; owl:sameAs ; dc:created "1999-01-01"^^xsd:date ; dc:established "1966-01-01"^^xsd:date ; skos:inScheme jvr: . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-DW8H3MNZ-P skos:prefLabel "Modulateurs GABA"@fr, "GABA Modulators"@en ; a mesh:Descriptor, skos:Concept . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept .